Related references
Note: Only part of the references are listed.High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma
Alain Bernheim et al.
LABORATORY INVESTIGATION (2008)
Primary salivary gland-type lung cancer - Spectrum of clinical presentation, histopathologic and prognostic factors
Julian R. Molina et al.
CANCER (2007)
Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non-adenoid cystic carcinoma malignant tumors of the salivary glands
Mark Agulnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib
Lela E. Buckingham et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model
Maher N. Younes et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Significance of EGFR protein expression and gene amplification in non-small cell luna carcinoma
Sanja Dacic et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Frequent EGFR mutations in noninvasive bronchioloalveolar carcinoma
S Matsumoto et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus
M Hanawa et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma
H Haneda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear β-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression
G Pelosi et al.
VIRCHOWS ARCHIV (2005)
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
N Thatcher et al.
LANCET (2005)
Epidermal growth factor receptor expression status in lung cancer correlates with its mutation
M Suzuki et al.
HUMAN PATHOLOGY (2005)
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: A Southwest Oncology Group Study
FR Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Erlotinib in lung cancer - Molecular and clinical predictors of outcome
MS Tsao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
EGFR mutations in non-small-cell lung cancer:: Analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment
A Marchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Protein expression and gene amplification of epidermal growth factor receptor in thymomas
DN Ionescu et al.
CANCER (2005)
Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers:: an immunohistochemical and fluorescent in situ hybridization study
A Ooi et al.
MODERN PATHOLOGY (2004)
Multiple reciprocal translocations in salivary gland mucoepidermoid carcinomas
G Tonon et al.
CANCER GENETICS AND CYTOGENETICS (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Epidermal growth factor receptor in non-small-cell lung carcinomas:: Correlation between gene copy number and protein expression and impact on prognosis
FR Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831
PC Roche et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands
MD Gibbons et al.
LARYNGOSCOPE (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Cell signaling by receptor tyrosine kinases
J Schlessinger
CELL (2000)
Share Paper
